CARGO Therapeutics, Company Overview

CARGO Therapeutics, logo
CARGO Therapeutics,
CARGO Therapeutics, primary media

About CARGO Therapeutics,

Cargo Therapeutics (NASDAQ:CRGX) is a clinical-stage biopharmaceutical company developing innovative medicines for hematologic malignancies, which are cancers of the blood and blood-forming tissues. Their lead candidate, rocatribor, is a targeted small molecule inhibitor currently in Phase 2 clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Cargo Therapeutics aims to leverage its scientific expertise and collaborative partnerships to bring life-changing therapies to patients with these challenging diseases.

What is CARGO Therapeutics, known for?

Snapshot

2019
Year founded
118
Employees
California, United States
Head office
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de CARGO Therapeutics,

  • Rocatribor: A targeted small molecule inhibitor currently in Phase 2 clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
  • CAR-T cell therapy: A personalized cellular therapy approach that involves engineering a patient's T cells to recognize and attack cancer cells.
  • CAR-NK cell therapy: Another form of cellular therapy using natural killer (NK) cells, which have the innate ability to recognize and kill cancer cells.
  • Bispecific T cell engagers (BiTEs): A type of immunotherapy that uses molecules to link T cells to cancer cells, triggering the immune system to destroy the cancer cells.
  • TCR-T cell therapy: A cellular therapy approach that uses T cells engineered with a specific T cell receptor (TCR) to recognize and target cancer cells.
  • Gene editing therapies: A new frontier in cancer treatment that uses technologies like CRISPR to modify genes and potentially cure cancer.

equipe executiva do CARGO Therapeutics,

  • Mr. Anup RadhakrishnanInterim CEO, CFO, Secretary, COO & Director
  • Dr. Crystal L. Mackall M.D.Co-Founder & Scientific Advisory Board Chair
  • Dr. Robbie Majzner M.D.Co-Founder & Scientific Advisory Board Member
  • Ms. Nancy Goodman J.D.Founder
  • Dr. Louai Labanieh Ph.D.Founder
  • Ms. Halley E. Gilbert Esq., J.D.Chief Legal Officer
  • Ms. Kari E. LeetchChief People Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.